Skip to main content

Neuroscience Biomarkers and Biosignatures Converging Technologies, Emerging Partnerships: Workshop Summary (2008) / Chapter Skim
Currently Skimming:

B Public Workshop on Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships
Pages 81-86

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 81...
... Welcome and Introductions ALAN LESHNER Forum Chair Chief Executive Officer, AAAS Executive Publisher, Science 81
Read the entire page →
From page 82...
... Lessons Learned from Alzheimer's Disease and the NIA Alzheimer's Disease Neuroimaging Initiative WILLIAM POTTER Vice President Merck Research Laboratories Clinical Neuroscience SESSION II: POTENTIAL TOOLS FOR BIOMARKER AND BIOSIGNATURE DEVELOPMENT Session Objective: Discuss which tools and parameters should be considered when developing a high-impact biomarker for the neurological or psychiatric disorders. ALAN BREIER, Session Chair Vice President for Medical and Chief Medical Officer Eli Lilly and Company 9:30 a.m.
Read the entire page →
From page 83...
... TOM INSEL, Session Chair Director National Institute of Mental Health 12:30 p.m. Which Psychiatric Disorders Are Primed for Key Advances in Biomarker Development?
Read the entire page →
From page 84...
... Current and Near-Term Impact of Biomarkers for Schizophrenia DAVID LEWIS Endowed Professor of Psychiatry University of Pittsburgh Medical Center 1:25 p.m. Current and Near-Term Impact of Biomarkers for Disorders of Addiction NORA VOLKOW Director National Institute on Drug Abuse 1:45 p.m.
Read the entire page →
From page 85...
... Current and Near-Term Impact of Biomarkers for Stroke STEVEN WARACH Chief Section on Stroke Diagnostics and Therapeutics National Institute of Neurological Disorders and Stroke 3:25 p.m. Current and Near-Term Impact of Biomarkers for SMA MEG WINBERG Research Director Spinal Muscular Atrophy Foundation 3:45 p.m.
Read the entire page →
From page 86...
... • What partnerships are needed to move forward? DENNIS CHOI, Workshop Chair Professor of Pharmacology & Experimental Therapeutics Boston University 5:30 p.m.
Read the entire page →

Key Terms

  • session chair
  • neurological disorders
  • tom insel
  • psychiatric disorders
  • chief medical

  • key advances
  • medical officer
  • novel biomarker
  • william potter
  • drug addiction

  • neuroimaging initiative
  • lewis endowed
  • deputy commissioner
  • howard schulman
  • forum chair

  • biosignature development
  • janet woodcock
  • development session
  • psychiatric medicine
  • insel director

  • ppd biomarker
  • lunch session
  • addiction disorders
  • neurological diseases
  • story landis

  • disease neuroimaging
  • dennis choi
  • disorders session
  • executive publisher
  • neurological medicine


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.